Cision PR Newswire

Asieris Pharmaceuticals Releases 2026 Semi-Annual Report: Core Product Commercialization Delivers, Entering a Harvest Period as the Company Accelerates Its Transition to Biopharma

SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Asieris Pharmaceuticals today released its 2026 Semi-Annual Report, showing comprehensive progress across all business segments. With the gradual realization of commercial launch and international expansion for its core products, the company is accelerating its transition from Biotech to Biopharma: CEVIRA®, the world's first...

NIPPON EXPRESS HOLDINGS Completes Procedure to Make Germany’s SH HoldCo Wholly-owned Subsidiary

- Completion of Acquisition (Subsidiarization) of SH HoldCo GmbH Shares - TOKYO, Feb. 14, 2025 /PRNewswire/ -- NIPPON EXPRESS HOLDINGS, INC. is pleased...

AWE’s Mega Event Lucky Draw – Round Two Delights

The Excitement Reaches New Heights HONG KONG, Feb. 14, 2025 /PRNewswire/ -- Following the success of round one lucky draw, AsiaWorld-Expo (AWE) proudly announces...